Fundraising Mechanics

Convertible Notes vs SAFEs: The Practical Differences

Silicon Fund Editorial Updated August 23, 2026 8 min read

Convertible notes and SAFEs solve the same basic problem: letting a startup raise money now while deferring a full valuation negotiation to later. But they are structured very differently, and those structural differences carry real consequences, especially when a company's growth doesn't go exactly to plan.

The core distinction: debt versus not-debt

A convertible note is a loan. It is debt on the company's books, it accrues interest, and it has a maturity date by which it must either convert into equity or be repaid. A SAFE, as covered in our guide to how SAFEs convert into equity, is not debt at all. It has no interest, no maturity date, and no repayment obligation. This single distinction is the source of almost every other practical difference between the two instruments.

Interest: notes accrue it, SAFEs don't

Because a convertible note is a loan, it typically carries a stated interest rate. That interest usually accrues over the life of the note and gets added to the principal amount when the note eventually converts, meaning the noteholder ends up converting a larger effective investment (principal plus accrued interest) into shares than they originally wrote a check for. SAFEs skip this mechanic entirely: the investor's conversion amount is simply what they originally invested.

Maturity dates: the practical risk SAFEs avoid

A convertible note has a maturity date, commonly somewhere between eighteen months and two years from issuance. If the note hasn't converted by then, because the company hasn't raised a qualifying priced round, the terms of the note determine what happens next: it might trigger a technical default, give the holder the right to demand repayment, or force a renegotiation. For an early-stage company that hasn't yet reached a priced round, an approaching maturity date on outstanding notes can become a real source of pressure, sometimes forcing a round to happen on a compressed timeline rather than when the company is actually ready. SAFEs remove this pressure entirely, since there's no date by which anything must happen.

A maturity date isn't just a paperwork detail. It's a clock that keeps running whether or not the business is ready for its next round.

Balance sheet and accounting treatment

Because notes are debt, they show up as a liability on the company's balance sheet, which can affect how the company's financial position is perceived by later investors or lenders. SAFEs are typically treated differently, generally not as debt, which is one reason many early-stage companies and investors have shifted toward SAFEs specifically to avoid carrying debt on an early-stage balance sheet.

Conversion mechanics are similar, but not identical

Both instruments typically use a valuation cap and/or a discount to determine their conversion price when a qualifying priced round happens, and the basic mechanic of "convert at whichever price is more favorable to the holder" applies to both. The meaningful difference is what happens to the accrued interest on a note (it gets added to the converting principal) and what happens if maturity is reached before any qualifying event (a risk unique to notes). Everything else about how dilution compounds once these instruments convert applies similarly to both.

Why the choice matters for founders

For founders, the practical tradeoff is this: SAFEs offer simplicity and remove the pressure of a looming maturity date, but a portfolio of investors may sometimes prefer the greater legal familiarity and formal creditor status that debt instruments provide, particularly investors more accustomed to traditional debt markets. Understanding which instrument a given investor is proposing, and reading the specific terms rather than assuming all SAFEs or all notes are identical, matters just as much as understanding the choice between a note or SAFE and a full priced round in the first place.

A quick side-by-side